Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.

Source:http://linkedlifedata.com/resource/pubmed/id/12359769

Cancer Res. 2002 Oct 1 62 19 5564-70

Download in:

View as

General Info

PMID
12359769